Immuron IMRN
NASDAQ IMRN
$0.97 -0.05 (-4.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Net Margin (2023 - 2024)

Updated

Immuron's Net Margin came in at -49.55% for FY2026 (year ended Aug 28, 2026), up 22.55 percentage points from -72.11% in FY2025.

Analysis

Immuron (IMRN) Net Margin (2023 - 2024) Analysis & Trends

Going back to FY2015, Immuron's Net Margin data covers 12 fiscal years.

  • Net Margin carries a five-year change of +5702.05 percentage points (FY2021 to FY2026).
  • The FY2026 figure represents the highest annual Net Margin in data going back to FY2015.
  • Per Business Quant, earlier fiscal years put Net Margin at -72.11% in FY2025, -141.44% in FY2024 (-53.43 pp), -88.01% in FY2023 (+233.30 pp) and -321.31% in FY2022 (+5430.30 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 21.86%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 21.27%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -8.04%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 16.30%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 23.62%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -134.51%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.65%
10 Immuron 7.32 Mn -9.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 9, 2024 -141.49%
Dec 31, 2023 -209.81%
API Access

Immuron Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IMRN&period=max&api_key=YOUR_API_KEY